Examining Hepatitis C Virus Treatment Access
A Review of Select State Medicaid Fee-For-Service and Managed Care Programs
Related Articles
-
-
Hep C Task Force Round Table Meeting Highlights | Brooklyn – 10-26-17
Hep C Task Force Round Table Meeting Highlights | Brooklyn – 10-26-17 Brooklyn Hep C Round Table Meeting Highlights October 26 (2:30 – 5:00 PM) Bedford Stuyvesant Restoration Plaza www.hepfree.nyc #HepFreeNYC #EndHepatitis In Attendance: See Below Next Meeting Date Tues...
-
Documentary | Hep B BE ABOUT IT now on YouTube!
In recognition of Liver Cancer Awareness Month, Gilead Sciences is excited to share that you can now watch BE ABOUT IT – the documentary highlighting the impact of chronic hep B on the Asian American community – on the Gilead YouTube channel!
-
FDA Approves Zepatier for Treatment of Hep C
The U.S. Food and Drug Administration has approved Zepatier with or without ribavirin for the treatment of chronic Hepatitis C genotypes 1 and 4 infections in adult patients.
-
LGBTQ Committee Meeting Highlights | 12-6-17
Committee members received printed copies of the Hep A and B vaccination card for MSM, and discussed engagement of trans folks around the topic of hepatitis (Hep C in particular).
-
NYC DOHMH’s Request to Upgrade USPSTF’s Baby Boomer HCV Testing Rating
The USPSTF's draft recommendations on testing hepatitis C among injection drug users and others at high risk is a major improvement over previous guidelines (a grade “B”, meaning testing is recommended).
-
Sign On | Letter to Congress for Increased Hep Funding (Due 3/4/16)
A letter from the Hepatitis Appropriations Partnership urges Congress to appropriate $62.8 million for the Division of Viral Hepatitis
-
Sign-On! Ask Congress to oppose cuts to domestic HIV/Hep and related programs in FY 2018.
Consider signing your organization on to the attached letter from ABAC urging Congress to reject the proposed budget cuts and adequately fund domestic HIV/Hep and related programs in FY 2018.
